Cargando…
Development of Oral Sustained Release Rifampicin Loaded Chitosan Nanoparticles by Design of Experiment
Objective. The main objective of the present investigation was to develop and optimize oral sustained release Chitosan nanoparticles (CNs) of rifampicin by design of experiment (DOE). Methodology. CNs were prepared by modified emulsion ionic gelation technique. Here, inclusion of hydrophobic drug mo...
Autores principales: | Patel, Bhavin K., Parikh, Rajesh H., Aboti, Pooja S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759266/ https://www.ncbi.nlm.nih.gov/pubmed/24024034 http://dx.doi.org/10.1155/2013/370938 |
Ejemplares similares
-
Development and In Vitro Release of Isoniazid and Rifampicin-Loaded Bovine Serum Albumin Nanoparticles
por: Ge, Zhaohui, et al.
Publicado: (2018) -
Preparation of 5-fluorouracil-loaded chitosan nanoparticles and study of the sustained release in vitro and in vivo
por: Sun, Li, et al.
Publicado: (2017) -
Dihydroartemisinin-Loaded Chitosan Nanoparticles Inhibit the Rifampicin-Resistant Mycobacterium tuberculosis by Disrupting the Cell Wall
por: Gu, Xiujuan, et al.
Publicado: (2021) -
Development of Sustained Release Baricitinib Loaded Lipid-Polymer Hybrid Nanoparticles with Improved Oral Bioavailability
por: Anwer, Md. Khalid, et al.
Publicado: (2021) -
Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain
por: Patel, Bhavin K, et al.
Publicado: (2018)